Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
Diluent
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Aventis Pharma, Dagenham, Essex, United Kingdom
Aventis Principes Actifs Pharmaceutiques, Vitry-Sur-Seine, France
Pierre Fabre Medicament Production, Etablissement Aquitaine Pharm International, Idron, France
Note: This consent is valid for two years from 23 May 2008.
Dated this 20th day of May 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).